AMMAR AL-OBAIDI
Internal Medicine Physician · WICHITA, KS
Individual Active NPI 1437643269
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 580 | 158,460 | $11,697,181 | $3,334,035 | $2,660,092 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 20,100 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 12,600 | $57 | $45 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 12,000 | $1 | $1 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 11,265 | $3 | $2 |
| J9299 | Injection, nivolumab, 1 mg | 9,560 | $31 | $25 |
| J0185 | Injection, aprepitant, 1 mg | 9,100 | $2 | $1 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 8,280 | $50 | $40 |
| J0897 | Injection, denosumab, 1 mg | 5,760 | $26 | $21 |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | 5,700 | $6 | $4 |
| J1930 | Injection, lanreotide, 1 mg | 3,360 | $49 | $39 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 3,036 | $23 | $19 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,923 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Internal Medicine Physician | 207R00000X | ✓ | 94-09623 | KS |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Internal Medicine Physician providers in Kansas
- NPI 1427749951
- NPI 1023660297
- NPI 1083344469
- NPI 1639971625
- NPI 1891628426
- NPI 1851396071
- NPI 1356012181
- NPI 1124298872
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.